Innocan Pharma Anticipates NYSE Listing with Concurrent Offering
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 27 2026
0mins
Should l Buy INN?
Source: Yahoo Finance
- Listing Plans: Innocan Pharma anticipates listing on NYSE American around January 30, 2026, contingent upon approval of its application and compliance with exchange rules, which will provide the company with broader access to capital markets.
- Concurrent Offering: The company is conducting a concurrent offering of its securities, with details to be disclosed through filings with the SEC and SEDAR+, expected to enhance the company's liquidity and market recognition.
- Trading Transition: Following the NYSE listing, trading of Innocan's common shares on OTCQB will terminate around January 29, 2026, a transition that is expected to improve the company's image and liquidity among investors.
- Business Development: Innocan's innovations in pharmaceuticals and wellness, particularly its CBD-loaded liposome drug delivery platform, are anticipated to further drive market share growth by addressing the demand for non-opioid pain management solutions.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy INN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on INN
Wall Street analysts forecast INN stock price to rise
2 Analyst Rating
0 Buy
1 Hold
1 Sell
Moderate Sell
Current: 4.130
Low
4.50
Averages
4.75
High
5.00
Current: 4.130
Low
4.50
Averages
4.75
High
5.00
About INN
Summit Hotel Properties, Inc. is a real estate investment trust. The Company is focused on owning premium-branded lodging facilities with operating models primarily in the upscale segment of the lodging industry. Its portfolio consists of over 95 assets, 52 of which are wholly owned, with a total of 14,347 guestrooms located in 24 states. Its lodging properties are located in markets with multiple demand generators, such as corporate offices and headquarters, retail centers, airports, state capitols, convention centers, universities, and leisure attractions. Its guestrooms operate under franchise brands owned by Marriott International, Inc. (Marriott), Hilton Worldwide (Hilton), Hyatt Hotels Corporation (Hyatt), and InterContinental Hotels Group (IHG). It holds both general and limited partnership interests in Summit Hotel OP, LP (the Operating Partnership). Substantially, all of its assets are held by, and all of its operations are conducted through, the Operating Partnership.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
VERTIV HOLDINGS, LUMENTUM HOLDINGS, COHERENT, AND ECHOSTAR SET TO ENTER S&P 500
New Additions to S&P 500: Vertiv Holdings, Lumentum Holdings, Coherent, and Echosstar are set to join the S&P 500 index.
Market Impact: The inclusion of these companies may influence market dynamics and investor strategies as they become part of a major stock index.
See More
VERTIV HOLDINGS, LUMENTUM HOLDINGS, COHERENT, AND ECHOSTAR TO BE ADDED TO S&P 500; ADDITIONAL COMPANIES TO ENTER S&P 100, S&P MIDCAP 400, AND S&P SMALLCAP 600
New Additions to S&P 500: Vert Holdings, Lumentum Holdings, CohereNT, and EchoStar are set to join the S&P 500 index.
Other Index Changes: Additional companies will be added to the S&P 100, S&P MidCap 400, and S&P SmallCap 600 indices.
See More
Summit Hotel Properties Q4 2025 Earnings Call Insights
- Demand Recovery: In Q4 2025, RevPAR improved by over 200 basis points compared to Q3, despite a 1.6% year-over-year decline, indicating stabilized demand patterns, particularly in midweek and corporate travel, allowing the company to increase rates across segments.
- Capital Recycling Success: The recent sale of three non-core hotels generated $51.3 million in proceeds, reducing near-term capital expenditure needs by $12.6 million; since 2023, 13 non-core hotels have been sold, raising approximately $200 million and significantly lowering future capex expectations.
- 2026 Outlook: Management expects full-year 2026 RevPAR growth of 0% to 3%, primarily driven by gains in average daily rates, with the upcoming FIFA World Cup anticipated to provide a significant market opportunity, potentially adding 50 to 75 basis points to RevPAR.
- Financial Performance: Fourth quarter adjusted EBITDA was $39.7 million, and adjusted FFO was $22.3 million or $0.18 per share; despite a 1.8% decline in RevPAR, the company improved profitability through lower interest expenses and share repurchases.
See More
Summit Hotel (INN) Earnings Call Transcript
See More
Summit Hotel Q4 FFO Matches Expectations with Revenue Beat
- Financial Performance: Summit Hotel reported a Q4 FFO of $0.16 per share, aligning with market expectations, which demonstrates the company's ability to maintain stable earnings amidst market fluctuations.
- Revenue Growth: The company achieved revenue of $174.96 million, reflecting a 1.2% year-over-year increase, surpassing analyst expectations by $2.09 million, indicating its resilience in a competitive hotel market.
- Preferred Stock Valuation: The valuation of Summit Hotel's preferred stock is considered attractive in the context of its current credit profile, potentially appealing to investors seeking high yields and enhancing its capital structure.
- Market Rating: Seeking Alpha's quantitative rating on Summit Hotel indicates market confidence in its future performance, reflecting investor focus on its dividend and earnings stability.
See More
Summit Hotel Properties Reports Key 2025 Financial Highlights
- Asset Sales and Capital Recycling: Summit Hotel Properties successfully sold three non-core hotels in Q4 2025 and Q1 2026, generating over $51 million in proceeds and significantly reducing near-term capital expenditure needs by $13 million, thereby optimizing the company's financial position.
- Revenue and Profit Performance: The total revenue for Q4 2025 reached $174.96 million, and despite challenges from reduced international travel and government demand, RevPAR growth improved by 240 basis points, indicating a gradual recovery in market demand.
- Debt Management and Liquidity: In February 2026, the company fully repaid $287.5 million of convertible notes using a $275 million delayed draw term loan, ensuring no debt maturities until 2028 and enhancing financial flexibility.
- Future Outlook and Market Demand: Looking ahead to 2026, Summit expects to benefit from major events like the World Cup, with projected RevPAR growth between 0% and 3%, reflecting an optimistic outlook on market recovery.
See More
VERTIV HOLDINGS, LUMENTUM HOLDINGS, COHERENT, AND ECHOSTAR SET TO ENTER S&P 500
New Additions to S&P 500: Vertiv Holdings, Lumentum Holdings, Coherent, and Echosstar are set to join the S&P 500 index.
Market Impact: The inclusion of these companies may influence market dynamics and investor strategies as they become part of a major stock index.
See More
VERTIV HOLDINGS, LUMENTUM HOLDINGS, COHERENT, AND ECHOSTAR TO BE ADDED TO S&P 500; ADDITIONAL COMPANIES TO ENTER S&P 100, S&P MIDCAP 400, AND S&P SMALLCAP 600
New Additions to S&P 500: Vert Holdings, Lumentum Holdings, CohereNT, and EchoStar are set to join the S&P 500 index.
Other Index Changes: Additional companies will be added to the S&P 100, S&P MidCap 400, and S&P SmallCap 600 indices.
See More
Summit Hotel Properties Q4 2025 Earnings Call Insights
- Demand Recovery: In Q4 2025, RevPAR improved by over 200 basis points compared to Q3, despite a 1.6% year-over-year decline, indicating stabilized demand patterns, particularly in midweek and corporate travel, allowing the company to increase rates across segments.
- Capital Recycling Success: The recent sale of three non-core hotels generated $51.3 million in proceeds, reducing near-term capital expenditure needs by $12.6 million; since 2023, 13 non-core hotels have been sold, raising approximately $200 million and significantly lowering future capex expectations.
- 2026 Outlook: Management expects full-year 2026 RevPAR growth of 0% to 3%, primarily driven by gains in average daily rates, with the upcoming FIFA World Cup anticipated to provide a significant market opportunity, potentially adding 50 to 75 basis points to RevPAR.
- Financial Performance: Fourth quarter adjusted EBITDA was $39.7 million, and adjusted FFO was $22.3 million or $0.18 per share; despite a 1.8% decline in RevPAR, the company improved profitability through lower interest expenses and share repurchases.
See More
Summit Hotel (INN) Earnings Call Transcript
See More
Summit Hotel Q4 FFO Matches Expectations with Revenue Beat
- Financial Performance: Summit Hotel reported a Q4 FFO of $0.16 per share, aligning with market expectations, which demonstrates the company's ability to maintain stable earnings amidst market fluctuations.
- Revenue Growth: The company achieved revenue of $174.96 million, reflecting a 1.2% year-over-year increase, surpassing analyst expectations by $2.09 million, indicating its resilience in a competitive hotel market.
- Preferred Stock Valuation: The valuation of Summit Hotel's preferred stock is considered attractive in the context of its current credit profile, potentially appealing to investors seeking high yields and enhancing its capital structure.
- Market Rating: Seeking Alpha's quantitative rating on Summit Hotel indicates market confidence in its future performance, reflecting investor focus on its dividend and earnings stability.
See More
Summit Hotel Properties Reports Key 2025 Financial Highlights
- Asset Sales and Capital Recycling: Summit Hotel Properties successfully sold three non-core hotels in Q4 2025 and Q1 2026, generating over $51 million in proceeds and significantly reducing near-term capital expenditure needs by $13 million, thereby optimizing the company's financial position.
- Revenue and Profit Performance: The total revenue for Q4 2025 reached $174.96 million, and despite challenges from reduced international travel and government demand, RevPAR growth improved by 240 basis points, indicating a gradual recovery in market demand.
- Debt Management and Liquidity: In February 2026, the company fully repaid $287.5 million of convertible notes using a $275 million delayed draw term loan, ensuring no debt maturities until 2028 and enhancing financial flexibility.
- Future Outlook and Market Demand: Looking ahead to 2026, Summit expects to benefit from major events like the World Cup, with projected RevPAR growth between 0% and 3%, reflecting an optimistic outlook on market recovery.
See More
